Fundraising Fox

Guard Therapeutics

1 known investors

guardtherapeutics.com β†—

Guard Therapeutics International is a biopharmaceutical company developing treatments for kidney disease, including its lead drug candidate RMC-035 and its GTX peptide platform. The Swedish company is listed on the Nasdaq First North Growth Market.

BiotechHealthtech

Founders & leadership

TA
Tobias AgervaldCEO

Investors Β· 1

IndustrifondenStockholm Β· $1.1M – $4.3M

In the news

Guard Therapeutics International AB (GUARD)morningstar.com Β· May 2026Guard Therapeutics Raises SEK120 Million from Rights Offering | MarketScreenermarketscreener.com Β· Apr 2025Industrifonden leads 120 million SEK financing round in Guard Therapeutics – Industrifondenindustrifonden.com Β· Nov 2022

Frequently asked questions

What does Guard Therapeutics do?
Guard Therapeutics International is a biopharmaceutical company developing treatments for kidney disease, including its lead drug candidate RMC-035 and its GTX peptide platform. The Swedish company is listed on the Nasdaq First North Growth Market.
Who are Guard Therapeutics's investors?
Guard Therapeutics's investors include Industrifonden.